Vedanta Limited said that it has received a detailed legal opinion from the former Chief Justice of India (CJI), Dr. D.Y.

Anthem Biosciences shares are expected to make strong listing gains on the back of bumper subscription and strong GMP trends.

Resisting those urges, no matter how “logical” they may seem, is good investment behavior. The temptation to react will ...

One Point One Solutions, a small-cap BPM service provider, is likely to draw market attention on Monday following its ...

In the week ahead, 112 S&P 500 companies are set to report quarterly results, with earnings season in full focus as the ...

The frosty relations between the U.S. and China adversely affected Nvidia. The new export restrictions meant the company ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

Key Points Exelixis' most important product should continue driving strong financial results through the end of the ...

Wall Street analysts predict lower second-quarter profits for Ford, GM and Stellantis due to tariff pressures and slowing sales.

Data center growth is slated to continue for some time. Nvidia's GPUs are unrivaled in the AI space. Nvidia (NASDAQ: NVDA) ...

Arq recognized that the PAC market is maturing, and it is investing in adding GAC capacity. Read why ARQ stock is not ...

"If retirement is at least five years away, it is not the time to panic," said Saavedra. That said, if you are nearing ...